| CEO: | Stuart Ashman |
| Executive Director: | Simon Hewitson |
| Independent Non-Executive Director: | Catherine Denise Prescott |
| Non-Executive Chairman: | Martin Braddock Hunt |
| Non-Executive Dir: | Danielle Bekker |
| Address: | The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF |
| Phone: | +44 191 495 7325 |
| Website: | http://www.skinbiotherapeutics.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BF33H870 |
| Currency | UK Pounds |
| Share Price | 13.63p |
| Change Today | 0.13p |
| % Change | 0.93 % |
| 52 Week High | 26.10 |
| 52 Week Low | 12.25 |
| Volume | 647,356 |
| Shares Issued | 258.78m |
| Market Cap | £35.26m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:15 | 26,402 @ 13.40p |
| 13:18 | 60,000 @ 13.64p |
| 12:40 | 10,968 @ 13.64p |
| 11:53 | 2,000 @ 13.65p |
| 10:20 | 12,431 @ 13.33p |
You are here: research